newsfilter
← Latest News
GlobeNewswire·

Rein Therapeutics to Present at Upcoming September Investor Conferences

AUSTIN, Texas, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ:RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines in orphan pulmonary and fibrosis